Search for: "Pharmacia " Results 21 - 40 of 172
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Sep 2017, 2:50 pm by Matt Pulle
Pharmacia & Upjohn Absence Payment Plan, (2006), the Sixth Circuit re-iterated that while “some weight is to be given” to an SSA determination of total disability, “it is not binding. [read post]
25 Jan 2017, 11:25 pm
He notes that the Neurim decision seems to be inconsistent with the CJEU’s decisions in MIT, GSK, Pharmacia and Yissum. [read post]
16 Jan 2017, 6:45 am by Brian Cordery
It is interesting to note that, on reviewing the authorities, Arnold J once again expressed concern regarding the compatibility of Neurim on the one hand and Pharmacia (C-31/03) and Yissum (C-202/05) on the other. [read post]
2 Nov 2016, 4:57 am by Amber Walsh
The healthcare and life sciences sectors have grown at a rapid pace during recent years. [read post]
26 Apr 2016, 1:16 pm by Lawrence B. Ebert
On April 28, 2000, PR Newswire reported results of a study in which Pharmacia found even at very high doses, Celebrex showed no increases in stroke or heart attack with or without aspirin. [read post]
21 Feb 2016, 1:44 am
These factors were then applied for the first time in Actavis v Pharmacia [2014] EWHC 2265 (the history of which is recorded in Rose J's judgment). [read post]
19 Feb 2016, 2:50 pm by Rebecca Tushnet
 RT: [See also the papers in the Xalatan/Travatan case, Pharmacia v. [read post]
9 Nov 2015, 3:37 pm by Adam Kielich
The Pharmacia Corporation Supplemental Pension Plan is operated by Pfizer and it is a non-qualified pension benefit. [read post]
26 Jul 2015, 9:59 pm by Patent Docs
Pharmacia & Upjohn Co. [read post]
7 Nov 2014, 5:52 am
We’ve made no secret of our distaste for the so called “heeding presumption” – that juries may presume that any alternative “adequate” warning would have been heeded by the plaintiff (or, in prescription medical product cases, the prescriber). [read post]
3 Nov 2014, 11:10 am by Ronald V. Miller, Jr.
 Others include: Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) What is the next step? [read post]
22 Jul 2014, 10:17 am by Ronald V. Miller, Jr.
 While AndroGel (Abbvie/Abbott) is one of the most popular of these treatments, they also include: Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/Glaxo) Testopel (Auxilium) The gist of it is that low testosterone treatments may double the risk of heart attack for young men with heart disease as well as for men 65 years of age and older,… [read post]
15 Jul 2014, 11:44 pm by Nietzer
Today I conclude my three-part series on mergers and acquisitions under the Foreign Corrupt Practices Act (FCPA) with a review of the post-acquisition phase. [read post]
16 Apr 2014, 5:35 am by Ronald V. Miller, Jr.
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Researchers have long suspected a link between testosterone treatment and the risk of heart attack, though millions of men who have been taking the hormonal treatments are just now learning of the… [read post]
9 Apr 2014, 5:00 am by D Daniel Sokol
Damien Geradin, George Mason University School of Law; Tilburg University - Tilburg Law and Economics Center (TILEC); Covington & Burling LLP describes When Competition Law Analysis Goes Wrong – The Italian Pfizer/Pharmacia Case. [read post]